Recent Advances in Computerized Fetal Monitoring in Labor

Editorial

Austin J Obstet Gynecol. 2018; 5(3): 1101.

Recent Advances in Computerized Fetal Monitoring in Labor

Ignatov PN*

Department of Fetal Medicine, Orthogyn Medical Center, Sofia, Bulgaria

*Corresponding author: Ignatov PN, Department of Fetal Medicine, Orthogyn Medical Center, Sofia, Bulgaria

Received: February 05, 2018; Accepted: March 16, 2018; Published: March 23, 2018

Abstract

More than two decades after the implementation of Computerized Cardiotocography (cCTG) in clinical practice, it is still hampered by controversies and lack of acceptance. This is mainly due to the fact that until now, there was no evidence that existing cCTG systems could reduce the likelihood of Cesarean delivery, forceps-assisted vaginal birth or adverse baby outcomes such as fetal hypoxia and/or acidaemia, brain injury due to lack of oxygen (neonatal seizures, hypoxic ischaemic encephalopathy), Apgar score less than seven at five minutes or admission to the Neonatal Intensive Care Unit (NICU). Recently however, it was demonstrated that monitoring of labor with a new cCTG system, called the “QSL Protocol”, which is based on external computerized CTG, leads to a significant decrease in the occurrence of fetal hypoxia and operative deliveries, compared to standard CTG alone. Nevertheless, prior to the adoption of QSL Protocol as a gold standard in daily clinical practice, larger randomized control trials need to be conducted to assess its potential to detect rarer adverse events and stillbirth.

Introduction

Cardiotocography (CTG) is the current gold standard for fetal monitoring during labor. It is being used globally, on a daily basis. However, interpreting CTG traces can prove challenging, mainly due to significant differences in existing clinical practice guidelines. Extensive research has found that the same CTG trace may elicit inconsistent interpretations between maternity care providers (inter-and intra-observer variability), [1-8] which is disconcerting given the impact of CTG traces on clinical decision-making [9]. CTG has a relatively low specificity (a high false positive rate) for identifying fetal hypoxia and associated complications. As a result, cardiotocographic findings incorrectly identified as normal delay necessary interventions, potentially increasing the risk of hypoxia or metabolic acidosis in the infant, which often leads to occurrence of neonatal complications like seizures, encephalopathies, cerebral palsy, cognitive and neurological disorders or stillbirths [6]. Conversely, a trace incorrectly identified as abnormal may result in unnecessary intervention, such as induction of labor or Cesarean delivery. Given these clinical implications, in the last 30 years, substantial research has investigated the impact of CTG monitoring in its current form. It appears that using continuous standard CTG during labor leads to a significant decrease in the risk of neonatal seizures, although it doesn’t decrease the risk of fetal hypoxia/acidosis and cerebral palsy. Interestingly, it was also associated with significantly higher rates of Cesarean sections and instrumental deliveries [9,10].

Can the Current State of Art be Improved?

It is currently assumed that existing observer variability in CTG interpretation can be minimized through the use of electronic algorithms, implemented in Expert Systems (ESs). Expert Systems (ESs) represent a type of applied artificial intelligence designed to assist in complex decision-making [11]. In a healthcare context, ESs synthesis a computerized knowledge base derived from expert opinion with individual patient data to guide users towards possible diagnosis or treatment decisions [11]. To process data, an ES may apply rule-based algorithms or neural networks (i.e. a model of pattern recognition based on previously collected data) [12]. Requirements for ESs vary; systems may be web-based or supported on a standalone personal computer. ESs are paperless and present data in realtime, which is critical in healthcare environments where changes in health status can occur rapidly. The potential for ESs in maternity care is well recognized, and as a result, there has been an increasing interest in developing ESs for CTG monitoring [9,13,14]. Whereas earlier versions displayed only limited successes, some advances have been made in intelligence software. Several observational studies have reported significantly improved levels of agreement between practitioners interpreting fetal heart rate patterns when assisted by an ES [13,15,16]. Nevertheless, until recently, there was no evidence that CTG with an ES reduces the likelihood of Cesarean delivery, forcepsassisted vaginal birth or adverse baby outcomes such as fetal hypoxia and/or acidaemia, brain injury due to lack of oxygen (neonatal seizures, hypoxic ischaemic encephalopathy), Apgar score less than seven at five minutes or admission to the Neonatal Intensive Care Unit (NICU). In late 2016, Ignatov et al. published the final results from a trial aiming to assess the effectiveness of a new ES called “QDS Protocol”. It was demonstrated that monitoring of labor with the QSL Protocol, which is based on external computerized CTG, leads to a significant decrease in the occurrence of fetal hypoxia and operative deliveries, compared to standard CTG alone [17].

The QDS Protocol in Details

This ES is based on indirect quantitative cardiotocography (qCTG) [18]. It is currently integrated in the NEXUS/OBSTETRICS software package, formerly known as ARGUS (Nexus GMT, Frankfurt, Germany), which is one of several recognized fetal monitoring systems. The interface of NEXUS/OBSTETRICS with the qCTG module is shown on (Figure 1).